Feature Channels:

Alzheimer's and Dementia

Add to Favorites Subscribe Share
fbshare-Alzheimer's and Dementia

Showing results

6170 of 1838
Newswise: The Brain’s Amyloid Buildup is Not a Powerful Measure of Alzheimer’s Disease Severity

Article ID: 717184

The Brain’s Amyloid Buildup is Not a Powerful Measure of Alzheimer’s Disease Severity

Perelman School of Medicine at the University of Pennsylvania

Researchers find fluorodeoxyglucose (FDG) PET is a better indicator of cognitive performance when compared to PET scans that detect amyloid protein.

Released:
8-Aug-2019 10:35 AM EDT
logo_A1_pms124_269-XL.png

Article ID: 717135

New Research Sheds Light on the Effects of Insulin on the Brain

University at Albany, State University of New York

Research out of the University at Albany sheds light on the effects that insulin has on our ability to form new memories and recall old ones

Released:
7-Aug-2019 4:35 PM EDT
Newswise: Kim Campbell, Alzheimer’s disease advocate and widow of music legend Glen Campbell, to keynote ANA2019 October 13

Article ID: 716976

Kim Campbell, Alzheimer’s disease advocate and widow of music legend Glen Campbell, to keynote ANA2019 October 13

American Neurological Association (ANA)

Kim Campbell, Alzheimer’s disease advocate and widow of Grammy Hall of Fame and Award-winning music legend Glen Campbell, will deliver the keynote address at the American Neurological Association Annual Meeting in St. Louis.

Released:
7-Aug-2019 7:05 AM EDT
AACC_HEX_Stacked.gif
  • Embargo expired:
    5-Aug-2019 5:15 PM EDT

Article ID: 716032

Findings That Could Help Identify Alzheimer’s Patients Who Will Benefit From Exercise Announced at the 71st AACC Annual Scientific Meeting

American Association for Clinical Chemistry (AACC)

A novel study has discovered metabolites that predict which Alzheimer’s patients are likely to see their symptoms improve with exercise therapy. These findings were unveiled today at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo, and could be used to develop a blood test to guide Alzheimer’s treatment.

Released:
24-Jul-2019 9:00 AM EDT
Newswise: UNC Center for Aging and Health Receives $3.75 Million Grant to Integrate Geriatrics throughout NC Primary Care Practices

Article ID: 716959

UNC Center for Aging and Health Receives $3.75 Million Grant to Integrate Geriatrics throughout NC Primary Care Practices

University of North Carolina School of Medicine

The UNC School of Medicine’s Center for Aging and Health has received a five-year, $3.75 million grant from the Health Resources and Services Administration (HRSA) to provide geriatrics training throughout North Carolina.

Released:
5-Aug-2019 3:55 PM EDT

Article ID: 716889

Model predicts cognitive decline due to Alzheimer's, up to two years out

Massachusetts Institute of Technology (MIT)

A new model developed at MIT can help predict if patients at risk for Alzheimer's disease will experience clinically significant cognitive decline due to the disease, by predicting their cognition test scores up to two years in the future.

Released:
2-Aug-2019 1:05 PM EDT
Newswise: Case Western Reserve School of Medicine Scientist Receives Major Grant for Diagnosis of Alzheimer’s, Parkinson’s Via New Skin Test

Article ID: 716867

Case Western Reserve School of Medicine Scientist Receives Major Grant for Diagnosis of Alzheimer’s, Parkinson’s Via New Skin Test

Case Western Reserve University

Wenquan Zou, MD, PhD, an expert in prion and degenerative neurological diseases, has received a two-year grant for developing diagnostic tools for Alzheimer’s disease, Parkinson’s disease, and other related brain-based degenerative disorders via an innovative skin test that uses ultrasensitive technology. The new test is much less invasive than evaluating brain tissue, which is the only approach for making a definitive diagnosis today.

Released:
2-Aug-2019 10:05 AM EDT
wau-logo.gif
  • Embargo expired:
    1-Aug-2019 4:00 PM EDT

Article ID: 716654

Blood test is highly accurate at identifying Alzheimer’s before symptoms arise

Washington University in St. Louis

A blood test to detect the brain changes of early Alzheimer’s disease has moved one step closer to reality. Researchers from Washington University School of Medicine in St. Louis report that they can measure levels of the Alzheimer’s protein amyloid beta in the blood and use such levels to predict whether the protein has accumulated in the brain. The findings represent a key step toward a blood test to diagnose people on track to develop the devastating disease before symptoms arise.

Released:
30-Jul-2019 3:05 PM EDT
aan-logo.gif
  • Embargo expired:
    31-Jul-2019 4:00 PM EDT

Article ID: 716444

Both Low and High Levels of Hemoglobin Linked to Increased Risk of Dementia

American Academy of Neurology (AAN)

Having either low or high levels of hemoglobin in your blood may be linked to an increased risk of developing dementia years later, according to a study published in the July 31, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Released:
26-Jul-2019 10:05 AM EDT
Newswise: The Medical Minute: Take steps to prevent Alzheimer’s Disease

Article ID: 716716

The Medical Minute: Take steps to prevent Alzheimer’s Disease

Penn State Health

Alzheimer’s Disease is the most common type of dementia. It slowly kills brain cells and is the fifth-leading cause of death for Americans age 65 and over. But contrary to popular belief, steps can be taken to slow it down.

Released:
31-Jul-2019 11:05 AM EDT

Showing results

6170 of 1838

Chat now!